Closed · RFA-PS-23-004 · CFDA 93.084 · Discretionary

Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$750K-$1M
Award range
Closed
Status
February 27, 2023
Close date
1
Expected awards

The verdict

Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $750,000 -- $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

$750K-$1M
award range
Closed
application status
1
expected award
93.084
CFDA program

Archived opportunity record

Long-Acting Injectables for the Treatment of… is closed (last close February 27, 2023). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 27, 2023

Posted Dec 22 Closes Feb 27

Est. Total Funding

$4,000,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

The purpose of this notice of funding opportunity is to support research on Long-Acting Injectable-Antiretroviral Therapy (LAI-ART) by implementing LAI-ART administration in both clinic and non-clinic settings (e.g., community pharmacies). A multi-site effectiveness-implementation research study designed to compare receiving LAI-ART in clinic or pharmacy settings with the oral standard-of-care for the treatment of HIV will offer a unique source of information for improving acceptability, availability, and uptake of LAI-ART. Implementation outcomes of interest include acceptability, perceived barriers and facilitators, feasibility, and sustainability. Health outcomes of interest include missed visits, on-time receipt of injections, and the HIV care continuum, including retention in care and viral load suppression. The data collected will describe real-world LAI-ART use among persons with HIV (PWH) in an era of multiple HIV treatment modalities. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.

Wide-open applicant board · 14 Grants.gov doors

Long-Acting Injectables for the Treatment of… prints 14 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +10 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). Only 24 other Centers for Disease Control and Prevention - ERA listings share this exact eligibility-code string (4% of 640).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Jocelyn Patterson Mosley fzp0@cdc.gov

What to do next

Long-Acting Injectables for the Treatment of… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.084 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants